Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery: A Phase II Study

NCT03184038 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University as lead sponsor.

NCT NCT03184038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03184038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery: A Phase II Study
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase
Not applicable
Overall status
Recruiting
Start date
February 21, 2017
Completion date
September 30, 2026
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the brain, metastatic malignant solid neoplasm